Alkem Laboratories (BOM:539523) E10: ₹ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539523 Alkem Laboratories Ltd BOM:539523
96 GF Score
Price ₹5,501.60
GF Value ₹6,176.06
Valuation Modestly Undervalued
View Full Analysis

What is Alkem Laboratories E10?

Alkem Laboratories BOM:539523 +3.03% 96 E10 is ₹ as of Jun. 2026. GuruFocus rates BOM:539523 with a GF Score™ of 96/100 and a GF Value™ of ₹6,176.06 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alkem Laboratories's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹43.488. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is for the trailing ten years ended in Jun. 2026.

During the past 12 months, Alkem Laboratories's average E10 Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-09-21), Alkem Laboratories's current stock price is ₹5501.60. Alkem Laboratories's E10 for the quarter that ended in Jun. 2026 was . Alkem Laboratories's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Alkem Laboratories was 54.99. The lowest was 32.36. And the median was 41.43.


Alkem Laboratories  (BOM:539523) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Alkem Laboratories was 54.99. The lowest was 32.36. And the median was 41.43.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Alkem Laboratories E10 Related Terms


Alkem Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Alkem Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkem Laboratories E10 Chart

Alkem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alkem Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BOM:539523 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkem Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's Shiller PE Ratio falls into.


BOM:539523
96GF Score
Alkem Laboratories Ltd BOM:539523
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkem Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alkem Laboratories's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=43.4876/167.3573*167.3573
=43.488

Current CPI (Jun. 2026) = 167.3573.

Alkem Laboratories Quarterly Data

per share eps CPI Adj_EPS
201609 23.650 105.961 37.353
201612 19.520 105.196 31.055
201703 11.460 105.196 18.232
201706 5.985 107.109 9.352
201709 26.819 109.021 41.169
201712 14.360 109.404 21.967
201803 5.610 109.786 8.552
201806 11.387 111.317 17.120
201809 21.283 115.142 30.935
201812 16.939 115.142 24.620
201903 13.997 118.202 19.818
201906 15.512 120.880 21.476
201909 31.017 123.175 42.142
201912 31.948 126.235 42.355
202003 15.788 124.705 21.188
202006 35.295 127.000 46.511
202009 39.481 130.118 50.781
202012 37.717 130.889 48.225
202103 20.072 131.771 25.493
202106 39.152 134.084 48.867
202109 45.520 135.847 56.079
202112 43.964 138.161 53.255
202203 8.998 138.822 10.847
202206 10.675 142.347 12.551
202209 27.670 144.661 32.012
202212 38.030 145.763 43.665
202303 5.937 146.865 6.765
202306 23.981 150.280 26.706
202309 51.898 151.492 57.333
202312 49.760 152.924 54.457
202403 24.552 153.035 26.850
202406 45.595 155.789 48.981
202409 57.595 157.882 61.052
202412 52.341 158.323 55.328
202503 25.581 157.552 27.173
202506 55.556 159.755 58.200
202509 63.987 162.289 65.985
202512 53.002 163.281 54.325
202603 19.777 164.272 20.148
202606 43.488 167.357 43.488

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹ mean?
Alkem Laboratories (BOM:539523) has a E10 of ₹ as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Alkem Laboratories and its competitors.
Is Alkem Laboratories' E10 too high?
Alkem Laboratories' current E10 is ₹. Overall, Alkem Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkem Laboratories' E10 compare to ZTS?
Alkem Laboratories' E10 of ₹ can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Alkem Laboratories and its competitors. Alkem Laboratories's current E10 is ₹. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alkem Laboratories (BOM:539523) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹6,176.06, compared to a current price of ₹5,501.60 — trading 10.9% below its estimated fair value. The current E10 is ₹. Alkem Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Alkem Laboratories (BOM:539523), the current E10 is ₹ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkem Laboratories (BOM:539523) Overvalued in 2026?

Based on GuruFocus' analysis, Alkem Laboratories stock appears to be undervalued. The current stock price of ₹5,501.60 is trading 10.9% below its estimated GF Value™ of ₹6,176.06. GuruFocus considers Alkem Laboratories to be Modestly Undervalued.

Key valuation signals for BOM:539523:

  • E10:
  • GF Value™: ₹6,176.06 vs. price of ₹5,501.60 (10.9% below fair value)
  • GF Score™: 96/100

No single metric tells the full story. See the BOM:539523 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alkem Laboratories Business Description

Other Exchanges ALKEM:India
Address Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
96GF Score

Get the complete analysis for BOM:539523

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5,501.60
Price
₹6,176.06
GF Value